BRWA
LABD icon

B. Riley Wealth Advisors’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

B. Riley Wealth Advisors’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,015
Closed -$95.7K – 1240
2025
Q1 		$95.7K Buy
+1,015
New +$74.3K ﹤0.01% 1223

Other funds holding LABD

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

B. Riley Wealth Advisors's LABD Position: Q2 2025 in Review

B. Riley Wealth Advisors sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2025, closing a stake of 1,015 shares — an estimated $95.7K sold.

B. Riley Wealth Advisors first reported a position in LABD in Q1 2025 and held it in 1 quarter. The position peaked at $95.7K in Q1 2025. 18 funds tracked by Wall St. Rank hold LABD as of Q2 2025.

  • B. Riley Wealth Advisors reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2025 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,015 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2025, an estimated $95.7K.
  • B. Riley Wealth Advisors first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2025 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $95.7K in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2025, filed 19 Aug 2025.